Our research team is well represented in the new Olo Cancer Cluster presentation book!

 

The new Oslo Cancer Cluster presentation book is out!

Have a look here: 

OCC presentation


More  
 
 

We will be at PIVAC 2017 at the end of September

 

 Marit Renee Myhre has been selected to give a talk at  the 17th International Conference on Progress in  Vaccination Against Cancer (PIVAC 2017) in Loutraki,  Corinth, Greece

 She will present our latest work on our new CD4-based therapy, make sure to have a look at the abstract if you want  to learn more !

 


More  
 
 

We will be at SITC 2017 this fall !

 

 

Nadia Mensali and Pierre Dillard will attend the 2017 meeting of the Society for Immunotherapy of Cancer (SITC) in Baltimore from the 8 to the 12th of November 2017.

They will present our latest work on Universal Killer 92 and our new CD4-based therapy, make sure to have a look at the abstract and to pass by their poster if you want to learn more !


More  
 
 

New publication: therapeutic T-cell receptors in healthy donor blood, is safety predictable?

 

Our team has published a new paper in Translational Cancer Research:


New publication in our team: therapeutic T-cell receptors in healthy donor blood, is safety predictable? by Hakan Köksal and Sébastien Wälchli.
They are commenting a paper published in 2017 in Blood by Jahn et al. that presents a novel TCR-based therapy trageting intracellular transcription factor. Make sure to have a look at both papers!


More  
 
 

We will be at PIVAC 2017 at the end of September

 

 Marit Renee Myhre has been selected to give a talk at  the 17th    International Conference on Progress in  Vaccination Against    Cancer (PIVAC 2017) in Loutraki,  Corinth, Greece

  She will present our latest work on our new CD4-based therapy, make sure to have a look at the abstract if you want    to learn more !

 


More